CHIP

CHIP Diagnostics is a biotechnology company specializing in the development of advanced in vitro diagnostic (IVD) solutions, with a primary focus on oncology and early disease detection. The company leverages its proprietary platform to analyze exosomes and other biomarkers, providing high-sensitivity tools for the diagnosis and monitoring of cancer, infectious diseases, and neurological conditions. Its pipeline includes multiple diagnostic products designed to improve patient outcomes through earlier intervention and personalized medicine. CHIP Diagnostics aims to transform the landscape of medical testing by integrating microfluidic technology with molecular analysis to deliver rapid and accurate clinical insights.